NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-175-2016-0-MT-41 ANTI-KRAS-G12D T CELL RECEPTORS MT EP 17749580.1 Issued
NCI E-175-2016-0-MK-40 ANTI-KRAS-G12D T CELL RECEPTORS MK EP 17749580.1 Issued
NCI E-175-2016-0-FI-29 ANTI-KRAS-G12D T CELL RECEPTORS FI EP 17749580.1 Issued
NCI E-175-2016-0-DE-31 ANTI-KRAS-G12D T CELL RECEPTORS DE EP 17749580.1 Issued
NCI E-175-2016-0-FR-30 ANTI-KRAS-G12D T CELL RECEPTORS FR EP 17749580.1 Issued
NCI E-175-2016-0-JP-07 ANTI-KRAS-G12D T CELL RECEPTORS JP National Stage 2019-505220 Issued
NHLBI E-124-2014-3-US-03 Devices and Methods For Closure Of Transvascular Or Transcameral Access Ports US National Stage 15/664,642 10045765 Issued PDF
CC E-096-2016-0-PCT-02 POWERED GAIT ASSISTANCE SYSTEMS PCT PCT PCT/US2017/044625 Expired
NIAID E-109-2007-1-US-15 DETECTION OF INFECTIOUS PRION PROTEIN BY SEEDED CONVERSION OF RECOMBINANT PRION PROTEIN US CON 15/665,323 Abandoned
NCI E-175-2016-0-PCT-02 ANTI-KRAS-G12D T CELL RECEPTORS PCT PCT PCT/US2017/044615 Expired
NIAID E-020-2018-0-CN-05 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN CN National Stage 201680008108.2 Abandoned
NCI E-175-2016-0-CA-04 ANTI-KRAS-G12D T CELL RECEPTORS CA National Stage 3032870 Pending
NIAID E-020-2018-0-MX-03 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN MX National Stage MX/a/2017/009889 Abandoned
NIAID E-181-2016-0-PCT-02 Zika Virus Vaccines PCT PCT PCT/US2017/044468 Expired
CC E-277-2015-0-PCT-02 TRANSPERINEAL IMAGING-GUIDED PROSTATE NEEDLE PLACEMENT PCT PCT PCT/US2017/044344 Expired
NIAID E-020-2018-0-US-04 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN US National Stage 15/547,365 Abandoned
NIAID E-300-2009-5-US-11 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US DIV 15/661,867 10035845 Issued PDF
NIAID E-060-2015-0-KR-12 Novel Multivalent Nanoparticle-Based Vaccines KR National Stage 10-2017-7021112 Pending
NCI E-040-2012-0-AU-25 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2017208279 Issued
NHLBI E-121-2016-1-SG-05 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE SG National Stage 11201810871W Issued
NHLBI E-121-2016-1-HK-07 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE HK EP 19130894.9 Issued
NHLBI E-121-2016-1-IE-13 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE IE EP 17754517.5 Issued
NHLBI E-121-2016-1-EP-03 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE EP National Stage 17754517.5 Issued
NHLBI E-121-2016-1-FR-10 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE FR EP 17754517.5 Issued
NHLBI E-121-2016-1-DE-09 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE DE EP 17754517.5 Issued
NHLBI E-121-2016-1-CH-08 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE CH EP 17754517.5 Issued
NHLBI E-121-2016-1-GB-11 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE GB EP 17754517.5 Issued
NIBIB E-232-2014-0-US-04 Resolution Enhancement for Light Sheet Microscopy Systems and Methods US National Stage 15/511,580 10401604 Issued PDF
NHLBI E-121-2016-1-PCT-01 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE PCT PCT COMB PCT/US2017/043774 Expired
NCI E-115-2016-0-PCT-02 Methods of Making 18F-Labeled Precursors and Peptides, Labeled C-MET Binding Peptides, and Methods of Use Thereof PCT PCT PCT/US2017/043694 Expired
NIAID E-020-2018-0-EP-06 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN EP National Stage 16701948.8 Abandoned
NCI E-276-2014-0-US-03 METHODS AND KITS FOR MEASURING AND QUANTIFYING DNA DOUBLE-STRANDED BREAKS USING GAMMA-H2AX AND H2AX US National Stage 15/545,402 10809268 Issued PDF
NCI E-292-2014-0-US-04 HYDROGELS AND USE THEREOF IN ANASTOMOSIS PROCEDURES US National Stage 15/545,647 10086108 Issued PDF
NINDS E-101-2012-1-US-21 Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS) US CON 15/656,035 Abandoned
NCI E-211-2016-0-PCT-02 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF PCT PCT PCT/US2017/043112 Expired
NCI E-211-2016-0-EP-06 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF EP National Stage 17746316.3 Issued
NCI E-211-2016-0-CA-04 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF CA National Stage 3031559 Issued
NCI E-211-2016-0-AU-03 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF AU National Stage 2017305170 Issued
NCATS E-282-2014-0-US-03 Inhibitors Of 3-phosphoglycerate Dehydrogenase US National Stage 15/543,643 11225469 Issued PDF
NCATS E-026-2016-0-US-10 Kinetin Derivatives US National Stage 15/543,826 10676475 Issued PDF
NIAID E-120-2001-0-US-90 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US DIV 15/650,482 10500264 Expired PDF
NCATS E-202-2016-4-PCT-01 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection PCT PCT COMB PCT/US2017/042231 Expired
NCATS E-202-2016-4-US-02 Compounds and Methods for Treatment and Prevention of Flavivirus Infection US ORD 15/650,568 Abandoned
NCATS E-202-2016-4-BR-03 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection BR National Stage BR112019000796-2 Pending
NIAID E-145-2004-3-US-06 Monoclonal Antibodies Against Orthopoxviruses US DIV 15/650,103 Abandoned
NCI E-282-2016-2-US-05 Methods For Pre-conditioning Patients For Cell Therapy US CON 15/649,369 10322146 Issued PDF
NCI E-126-2016-0-PCT-02 IL-15/IL-15 RECEPTOR ALPHA TREATMENT REGIMENS AND USE WITH THERAPEUTIC VACCINES PCT PCT PCT/US2017/042002 Expired
NCI E-275-2014-0-US-06 FUROQUINOLINEDIONES AS INHIBITORS OF TDP2 US National Stage 15/542,560 10906914 Issued PDF
NCATS E-203-2012-0-US-08 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 US CON 15/645,683 10413548 Issued PDF
NCI E-278-2014-0-US-03 USE OF PEPTIDE-BASED INHIBITORS OF THE STAT3-IL 10 PATHWAY FOR TREATING BACTERIAL INFECTION AND GRANULOMATOUS DISEASE US National Stage 15/541,871 10512673 Issued PDF